Galimat Khaidakova, MD
Vascular Surgery · Anchorage, AKNPI 1245627744
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,365 of the $4,501 with a category attached, or 74.8%. 7 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 47.4% of the total. Reporting peaked in 2024 at $2,226 and has fallen 95.8% since, to $93 in 2025.
Across 26 payments — averaging $173.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$2K
- Medtronic$114
- Inari Medical, Inc.$77
- Stryker$58
- Boston Scientific$55
- plus $42 from 1 others
What the payments were for
- Travel & lodging$3,36575%
- Food & beverage$1,13625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 6 | $2,136 |
| Silk Road Medical, Inc. | 11 | $2,019 |
| Medtronic | 1 | $114 |
| Inari Medical, Inc. | 3 | $77 |
| Stryker | 1 | $58 |
| Boston Scientific | 3 | $55 |
| Atricure, Inc. | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few vascular surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $11,883 |
| XareltoRivaroxaban | 17 | $11,564 |
| Enoxaparin Sodium | 18 | $1,136 |
| ClopidogrelClopidogrel Bisulfate | 70 | $631 |
| Cilostazol | 13 | $110 |
| Tramadol Hcl | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Anchorage
- Jonathan McDonaghAnchorage$9K
- Jonathan BarnesAnchorage$8K
- Stanley WatkinsAnchorage$7K
- Priya PatelAnchorage$6K
- Seth KraussAnchorage$1K
- April RodriguezAnchorage$997
- Milan BajmocziFairbanks$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.